Fulgent Genetics, Inc. financial data

Symbol
FLGT on Nasdaq
Industry
Services-Medical Laboratories
Location
4399 Santa Anita Ave, El Monte, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Fulgent Diagnostics, Inc. (to 7/15/2016)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 542 % -29.7%
Debt-to-equity 8.98 % +10.2%
Return On Equity -14.6 % -191%
Return On Assets -13.4 % -188%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.6M shares +3.22%
Common Stock, Shares, Outstanding 30.5M shares +1.67%
Entity Public Float 629M USD -35.7%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.4M shares +1.34%
Weighted Average Number of Shares Outstanding, Diluted 30.4M shares +1.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 278M USD -3.02%
Cost of Revenue 177M USD -8.77%
Research and Development Expense 48.7M USD +28.1%
Selling and Marketing Expense 37.2M USD -9.73%
General and Administrative Expense 95.5M USD +10.9%
Operating Income (Loss) -209M USD -158%
Nonoperating Income (Expense) -1.45M USD -122%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -189M USD -203%
Income Tax Expense (Benefit) -17.2M USD -752%
Net Income (Loss) Attributable to Parent -165M USD -160%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58M USD -31%
Accounts Receivable, after Allowance for Credit Loss, Current 57.3M USD +16.3%
Other Assets, Current 56.2M USD +71.3%
Assets, Current 327M USD -40.6%
Property, Plant and Equipment, Net 107M USD +25.3%
Operating Lease, Right-of-Use Asset 5.97M USD -51.9%
Intangible Assets, Net (Excluding Goodwill) 137M USD -5.1%
Goodwill 22.1M USD -84.5%
Other Assets, Noncurrent 39M USD +2.32%
Assets 1.23B USD -9.18%
Accounts Payable, Current 19.8M USD +25.6%
Accrued Liabilities, Current 23.9M USD +13.5%
Contract with Customer, Liability, Current 2.97M USD +14.7%
Liabilities, Current 74M USD +20.5%
Deferred Income Tax Liabilities, Net 6.73M USD -31.5%
Operating Lease, Liability, Noncurrent 4.66M USD -39.3%
Other Liabilities, Noncurrent 11.8M USD -25%
Liabilities 98.9M USD +2.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9.18M USD
Retained Earnings (Accumulated Deficit) 596M USD -21.7%
Stockholders' Equity Attributable to Parent 1.14B USD -9.55%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.13B USD -10.1%
Liabilities and Equity 1.23B USD -9.18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.27M USD
Net Cash Provided by (Used in) Financing Activities -2.81M USD -155%
Net Cash Provided by (Used in) Investing Activities -47.2M USD -984%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 33.3M shares +4.34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.8M USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 58.2M USD -30.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 439K USD
Deferred Tax Assets, Valuation Allowance 15.9M USD +461%
Deferred Tax Assets, Gross 45.7M USD -19.2%
Operating Lease, Liability 6.14M USD -51.5%
Depreciation 16.8M USD -18.8%
Payments to Acquire Property, Plant, and Equipment 4.06M USD +99.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -139M USD -153%
Lessee, Operating Lease, Liability, to be Paid 7.39M USD -47%
Property, Plant and Equipment, Gross 156M USD +17.8%
Operating Lease, Liability, Current 1.48M USD -70.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.15M USD -52.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.74M USD -60%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +24.9%
Deferred Income Tax Expense (Benefit) -557K USD +89.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.24M USD -0.24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.04M USD -41.5%
Deferred Tax Assets, Operating Loss Carryforwards 17.5M USD +7.04%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 6.33M USD -33.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 516K USD -69.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7.93M USD +0.43%
Depreciation, Depletion and Amortization 25.3M USD -7.77%
Deferred Tax Assets, Net of Valuation Allowance 29.8M USD -44.5%
Share-based Payment Arrangement, Expense 45.5M USD +9.62%
Interest Expense 498K USD +134%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%